内毒素血症巨噬细胞HMGB1的表达及丙酮酸乙酯对其的抑制作用
摘要
目的:脓毒症是由细菌感染引起的一种致死性、全身性炎症反应,是临床危重患者主要的死亡原因之一。脓毒症发生发展的根本原因在于机体过度释放细胞因子和炎性介质,导致炎症反应失控和免疫功能紊乱。因此,细胞因子和炎性介质在脓毒症的发生发展中起十分重要的作用。高迁移率族蛋白B1(high mobility group protein B1,HMGB1)是近年研究发现的脓毒症“晚期”炎性介质,是脓毒症发生发展中起关键性作用的细胞因子,其在脓毒症中的作用得到越来越多的关注和重视,但脓毒症时HMGB1释放的具体分子机制尚未完全阐明。本研究拟首先采用内毒素(脂多糖,lipoplysaccharide,LPS)刺激巨噬细胞,观察LPS刺激后巨噬细胞中HMGB1、肿瘤坏死因子α(Tumor necrosis factor alpha ,TNF-α)和白细胞介素6 (Interleukin-6,IL-6)释放和表达的水平,并测定LPS刺激后巨噬细胞核转录因子-κB (Nuclear facror kappa B , NF-κB )、P38丝裂原活化蛋白激酶( P38 Mitogen-activated protein kinase,p38MAPK)和CREB结合蛋白(CREB binding protein,CBP)的活性变化,以期阐明LPS刺激巨噬细胞HMGB1释放的规律及其分子机制;其次,分别采用LPS、LPS+丙酮酸乙酯刺激巨噬细胞,检测巨噬细胞HMGB1、TNF-α、IL-6释放和表达的水平,并测定巨噬细胞NF-κB、p38MAPK、CBP的活性变化,比较LPS和LPS+丙酮酸乙酯刺激后巨噬细胞HMGB1释放和表达水平的变化以及
objective:
Sepsis is a lethal systemic inflammatory reaction caused by bacterial infection. It is one main causes of death in clinical severe patients. The basic reason of sepsis happened and developed is the excessive delivery of cytokines and inflammatory mediators by organism, which leads to the inflammatory reaction loss of control and immune function disorder. Therefore, the cytokines and inflammatory mediators play an important role in the development of sepsis. High mobility group protein box1 (HMGB1) is a kind of advanced stage inflammatory mediators discovered recently. It is the critical inflammatory mediators in generation and development of sepsis. And more and more people pay close attention to it’s role in sepsis. But the molecule mechanisms of HMGB1 release in sepsis are still unknown. Firstly, we used endotoxin (lipopolysaccharide,LPS) to stimulate macrophages and observed the releasing and expressing level of HMGB1, tumor necrosis factor alpha (TNF-α) and Interleukin-6 (IL-6).Then we determined the activity changes of Nuclear factor kappa B (NF-κB)﹑P38 mitogen activated protein kinase (p38MAPK) and CREB binding protein (CBP), in order to elucidate the release rule and molecule mechanisms of HMGB1 after stimulated by LPS. Secondly, we detected the releasing and expressing level of HMGB1, TNF-αand IL-6 in macrophages stimulated by LPS﹑LPS+ethyl pyruvate(EP) respectively
objective:
Sepsis is a lethal systemic inflammatory reaction caused by bacterial infection. It is one main causes of death in clinical severe patients. The basic reason of sepsis happened and developed is the excessive delivery of cytokines and inflammatory mediators by organism, which leads to the inflammatory reaction loss of control and immune function disorder. Therefore, the cytokines and inflammatory mediators play an important role in the development of sepsis. High mobility group protein box1 (HMGB1) is a kind of advanced stage inflammatory mediators discovered recently. It is the critical inflammatory mediators in generation and development of sepsis. And more and more people pay close attention to it’s role in sepsis. But the molecule mechanisms of HMGB1 release in sepsis are still unknown. Firstly, we used endotoxin (lipopolysaccharide,LPS) to stimulate macrophages and observed the releasing and expressing level of HMGB1, tumor necrosis factor alpha (TNF-α) and Interleukin-6 (IL-6).Then we determined the activity changes of Nuclear factor kappa B (NF-κB)﹑P38 mitogen activated protein kinase (p38MAPK) and CREB binding protein (CBP), in order to elucidate the release rule and molecule mechanisms of HMGB1 after stimulated by LPS. Secondly, we detected the releasing and expressing level of HMGB1, TNF-αand IL-6 in macrophages stimulated by LPS﹑LPS+ethyl pyruvate(EP) respectively
引文
[1] Angus DC,Linde-Zwirble WT,Lidicker J,et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care[J]. Crit Care Med,2001,29(7):1303-1310
[2] Martin GS,Mannino DM,Eaton S,et al. The epidemiology of sepsis in the United States from 1979 through 2000[J].N Engl J Med,2003,348(16):1546-1554
[3] Tracey KJ,Beutler B,Lowry SF,et al. Shock and tissue injury induced by recombinant human cachectin[J]. Science,1986,234(4775):470-474
[4]Dinarello CA. The interleukin-1 family:10 years of discovery[J].FASEB J,1994,8(15):1314-1325
[5] Moldawer LL. Biology of proinflammatory cytokines and their antagonists[J]. Crit Care Med,1994,22(7):3-7
[6] Michie HR,Spriggs DR,Manogue KR,et al. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings[J]. Surgery,1988,104(2):280-286
[7] Michie HR,Manogue KR,Spriggs DR,et al. Detection of circulating tumor necrosis factor after endotoxin administration[J]. N Engl J Med,1988,318(23):1481-1486
[8] Beutler B,Milsark IW,Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin[J]. Science,1985,229(4716):869-871
[9] Tracey K J,Beutler B,Lowry SF,et al. Shock and tissue injury induced by recombinant human cachectin[J]. Science,1986,234(4775):470-474
[10]Tracey KJ,Fong Y,Hesse DG,et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia[J]. Nature, 1987,330(6149): 662-664
[11]Reinhart K,Karzai W. Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned[J]. Crit Care Med,2001,29(Suppl.):121-125
[12]Eskandari MK,Bolgos G,Miller C,et al. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia[J]. JImmunol,1992,148(9):2724-2730
[13]Marino MW,Dunn A,Grail D,et al. Characterization of tumor necrosis factor-deficient mice[J]. Proc Natl Acad Sci USA,1997,94(15): 8093-8098
[14]Wang HC,Bloom O,Zhang MH,et al. HMG-1 as a late mediator of endotoxin lethality in mice[J]. Science,1999,285(5425):248-251
[15]Wang H,Li W,Li J,et al. The aqueous extract of a popular herbal nutrient supplement,Angelica sinensis,protects mice against lethal endotoxemia and sepsis[J]. J Nutr,2006,136(2):360-365
[16]Lin X,Yang H,Sakuragi T,et al. Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis[J]. Am J Physiol Lung Cell Mol Physiol,2005,289(4):583-590
[17]Sunden-Cullberg J,Norrby-Teglund A,Treutiger CJ. The role of high mobility group box-1 protein in severe sepsis[J]. Curr Opin Infect Dis,2006,19(3):231–236
[18]Bustin M. Revised nomenclature for high mobility group (HMG)chromosomal proteins[J]. Trends Biochem Sci,2001,26(3):152-153
[19]Thomas J O. HMG1 and 2:architectural DNA-binding proteins[J].Biochem Soc Trans,2001,29(4):395-401
[20]Bonaldi T,Langst G,Strohner R,et al. The DNA chaperond HMGB1 facilitates ACF/CHRAC-dependent nucleosome sliding[J]. EMBO J,2002,21(24):6865-6873
[21]Christopher JC,Huan Yang,Kevin JT. High mobility group box-1 as a therapeutic target downstream of tumor necrosis factor[J]. J Infect Dis,2003,187(Suppl 2):S391-396
[22]Treutiger CJ,Mullins GE,Johansson AS,et al. High mobility group 1 B-box mediates activation of human endothelium[J]. J Intern Med,2003,254(4):378-385
[23]Fiuza C,Bustin M,Talwar S,et al. Inflammatory promoting activity of HMGB1 on human microvascular endothelial cells[J]. Blood,2003,101(7):2652-2660
[24]Pachot A,Monneret G,Voirin N,et al. Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock[J]. Clinical Immunology,2005,114(1):61-69
[25]Harris HE,Andersson U. The nuclear protein HMGB1 as a proinflammatory mediator[J]. Eur J Immunol,2004,34(6):1503-1512
[26]Tang D,Shi Y,Jang L,et al. Heat shock response inhibits release of high mobility group box 1 protein induced by endotoxin in murine macrophages[J]. Shock,2005,23(5):434-440
[27]Lin X,Yang H,Sakuragi T,et al. Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis[J]. Am J Physiol Lung Cell Mol Physiol,2005,289(4):583-590
[28]Yin K,Gribbin E,Wang H. Interferon-gamma inhibition attenuates lethality after cecal ligation and puncture in rats: implication of high mobility group box-1[J]. Shock,2005,24(4):396-401
[29]Mantell LL,Parris WR,Ulloa L. Hmgb-1 as a therapeutic target for infectious and inflammatory disorders[J]. Shock,2006,25(1):4-11
[30]Chen X,Li W,Wang H. More tea for septic patients?--Green tea may reduce endotoxin-induced release of high mobility group box 1 and other pro-inflammatory cytokines[J]. Med Hypotheses,2006,66(3):660-663
[31]Das UN. Pyruvate is an endogenous anti-inflammatory and anti-oxidant molecule[J]. Med Sci Monit,2006,12(5):79-84
[32]Ulloa L,Ochani M,Yang H,et al. Ethylpyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation[J]. Proc Natl Acad Sci,2002,99(19):12351-12356
[33]Allan Tsung,Takashi Kaizu,Atsunori Nakao,et al. Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptosis[J]. Transplantation,2005,79(2):196-204
[34]Yang R,Uchiyama T,Watkins SK,et al. Ethyl pyruvate reduces liver injury in a murine model of extrahepatic cholestasis[J]. Shock,2004,22(4):369-375
[35]Yang R,Uchiyama T,Alber SM,et al.Ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis[J]. Crit Care Med,2004,32(7):1453-1459
[36]Alexandre P,Guillaume M,Nicolas V,et al. Longitudinal study of cytokine andimmune transcription factor mRNA expression in septic shock[J]. Clin Immuno,2005,114(1):61-69
[37]Beatriz RM,Mahendar O,Jianhua Li,et al. IFN-γ induces high mobility group Box 1 protein release partly through a TNF-dependent mechanism[J]. J Immuno,2003,170(7):3890–3897
[1]Angus DC,Linde-Zwirble WT,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care[J].Crit Care Med,2001,29:1303-1310
[2]Tracey KJ,Beutler B,Lowry SF,et al.Shock and tissue injury induced by recombinant human cachectin[J].Science,1986,234(4775):470-474
[3]Dinarello CA.The interleukin-1 family: 10 years of discovery[J]. FASEB J,1994,8(15):1314-1325
[4]Moldawer LL.Biology of proinflammatory cytokines and their antagonists[J].Crit Care Med,1994,22(7):3-7
[5]Beutler B,Milsark IW,Cerami AC.Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin[J].Science,1985,229:869-871
[6]Tracey K J,Beutler B,Lowry SF,et al.Shock and tissue injury induced by recombinant human cachectin[J].Science,1986,234:470-474
[7]Tracey KJ,Fong Y,Hesse DG,et al.Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia[J].Nature,1987,330:662-664
[8]Reinhart K,Karzai W.Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned[J].Crit Care Med,2001,29(Suppl):121-125
[9]Eskandari MK,Bolgos G,Miller C,et al.Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia[J].J Immunol,1992,148:2724-2730
[10]Beatriz RM,Mahendar O,Jianhua Li,et al.IFN-γ induces high mobility group Box 1 protein release partly through a TNF-dependent mechanism[J].The Journal of Immunology,2003,170:3890-3897
[11]Bustin M,Reeves R.High mobility group chrosomosomal proteins: architectural components that facilitate chromatin function[J].Prog Nucleic Acid Res Mol Biol,1996,54:35-100
[12]Melvin VS,Edwards DP.Coregulatory proteins in steroid hormone receptor action:the role of chromatin high mobilitygroup proteins HMGB-1 and-2[J].Steroids,1999,64:576-586
[13]Bustin M.Revised nomenclature for high mobility group (HMG) chromosomal proteins[J].Trends Biochem Sci,2001,26(3):152-153
[14]Thomas JO.HMG1 and 2:architectural DNA-binding proteins[J]. Biochem Soc Trans,2001,29(4):395-401
[15]Bonaldi T,Langst G,Strohner R,et al.The DNA chaperond HMGB1 facilitates ACF/CHRAC-dependent nucleosome sliding[J].EMBO J,2002,21(24): 6865-6873
[16]Sun NK,Chao CC.The cytokine activity of HMGB1--extracellular escape of the nuclear protein[J].Chang Gung Med J,2005,28(10):673-682
[17]Sapojnikova N,Maman J,Myers FA,et al.Biochemical observation of the rapid mobility of nuclear HMGB1[J].Biochim Biophys Acta,2005,1729(1):57-63
[18]Li W,Sama AE,Wang H.Role of HMGB1 in cardiovascular diseases[J]. Curr Opin Pharmacol,2006,6(2):130-135
[19]Merenmies J,Pihlaskari R,Laitinen J,et al.30-kDa heparin-binding protein of brain (amphoterin)involved in neurite outgrowth:amino acid sequence and localization in the filopodia of the advancing plasma membrane[J].J Biol Chem , 1991 ,266:16722-16729
[20]Daston MM,Ratner N.Expression of p30,a protein with adhesive properties,in Schwann cells and neurons of the developingand regenerating peripheral nerve[J].J Cell Biol,1991,112:1229-1239
[21]Parkkinen J,Rauvala H.Interactions of plasmingenand tissue plasmingen avtivator (t-PA) with amphoterin[J].J BiolChem,1991,266:16730-16735
[22]Brickman JM,Adam M,Ptashine M.Interactionsbetween an HMGB1 protein and members of the Rel family[J].Proc Natl Acad Sci USA,1999,96:10679- 10683
[23]Wang HC,Bloom O,Zhang MH,et al.HMG-1 as a late mediator of endotoxin lethality in mice[J].Science,1999,285:248-251
[24]Fang Wenhui,Yao Yongming,Shi Zhiguo,et al.The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury[J].Shock,2002,17:329-333
[25]Wang H,Li W,Li J,et al.The aqueous extract of a popular herbal nutrientsupplement,Angelica sinensis,protects mice against lethal endotoxemia and sepsis[J].J Nutr,2006,136(2):360-365
[26]Lin X,Yang H,Sakuragi T,et al.Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis[J].Am J Physiol Lung Cell Mol Physiol,2005,289(4):583-590
[27]Sunden-Cullberg J,Norrby-Teglund A,Treutiger CJ.The role of high mobility group box-1 protein in severe sepsis[J].Current Opinion in Infectious Diseases,2006,19:231-236
[28]Christopher JC,Huan Yang,Kevin JT.High mobility group box-1 as a therapeutic target downstream of tumor necrosis factor[J].The Journal of Infectious Diseases,2003,187(supple2):391-396
[29]Treutiger CJ,Mullins GE,Johansson AS,et al.High mobility group 1 B-box mediates activation of human endothelium[J].J Intern Med,2003,254:378-385
[30]Fiuza C,Bustin M,Talwar S,et al.Inf lammatory promoting activity of HMGB1 on human microvascular endothelial cells[J].Blood,2003,101: 2652-2660
[31]Pachot A,Monneret G,Voirin N,et al.Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock[J]. Clinical Immunology,2005,114:61-69
[32]Harris HE,Andersson U.The nuclear protein HMGB1 as a pro- inflammatory mediator[J].Eur J Immunol,2004,34:1503-1512
[33]Widmann C,Gibson S,Jarpe MB,et al.Mitogen activated protein kinase: conservation of a three-kinase module from yeast to human[J].Physiol Rev,1999,79(1):143-180
[34]Yang RB , Mark MR , Gurney AL , et al.Signaling events induced by lipopolysaccharide-activated toll-like receptor 2[J].J Immunol , 1999 , 163(2):639-643
[35]Baldwin AS.The NF-kappa B and I kappa B proteins: new discoveries and insights[J].Annu Rev Immunol,1996,14:649-683
[36]O’Neill LA.The role of MyD88-like adapters in Toll-like receptor signal transduction[J].Biochem Soc Trans,2003,31:643-647
[37]Harris HE,Andersson U.The nuclear protein HMGB1 as a pro- inflammatory mediator[J].Eur J Immunol,2004,34:1503-1512
[38]Gardella S,Andrei C,Ferrera D,et al.The nuclear protein HMGB1 is secreted by monocytes via a non-classical,vesicle-mediated[J].EMBO Rep,2002,3:995-1001
[39]Bonaldi T,Talamo F,Scaffidi P,et al.Monocytic cells hyEPracetylate chromat in protein HMGB1 to redirect it towards secretion[J].The EMBO Journal,2003,22(20):5551-5560
[1]Tracey KJ,Beutler B,Lowry SF,et al.Shock and tissue injury induced by recombinant human cachectin[J].Science,1986,234(4775):470-474
[2]Dinarello CA.The interleukin-1 family: 10 years of discovery [J].FASEB J,1994,8(15):1314-1325
[3]Moldawer LL.Biology of proinflammatory cytokines and their antagonists[J].Crit Care Med,1994,22(7):3-7
[4]Michie HR,Spriggs DR,Manogue KR,et al.Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings[J].Surgery,1988,104:280-286
[5]Michie HR,Manogue KR,Spriggs DR,et al.Detection of circulating tumor necrosis factor after endotoxin administration[J].N Engl J Med,1988,318:1481-1486
[6]Beutler B,Milsark IW,Cerami AC.Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin[J].Science,1985,229:869-871
[7]Tracey K J,Beutler B,Lowry SF,et al.Shock and tissue injury induced by recombinant human cachectin[J].Science,1986,234:470-474
[8]Tracey KJ,Fong Y,Hesse DG,et al.Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia[J].Nature, 1987,330:662-664
[9]Reinhart K,Karzai W.Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned[J].Crit Care Med,2001,29(Suppl):121-125
[10]Eskandari MK,Bolgos G,Miller C,et al.Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia[J].J Immunol,1992,148:2724-2730
[11]Wang HC,Bloom O,Zhang MH,et al.HMG-1 as a late mediator of endotoxin lethality in mice[J].Science,1999,285:248-251
[12]Fang Wenhui,Yao Yongming,Shi Zhiguo,et al.The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury[J].Shock,2002,17:329-333
[13] Wang H,Li W,Li J,et al.The aqueous extract of a popular herbal nutrient supplement, Angelica sinensis, protects mice against lethal endotoxemia andsepsis[J].J Nutr,2006,136(2):360-365
[14]Lin X,Yang H,Sakuragi T,et al.Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis[J].Am J Physiol Lung Cell Mol Physiol,2005,289(4):583-590
[15]Sunden-Cullberg J,Norrby-Teglund A,Treutiger CJ.The role of high mobility group box-1 protein in severe sepsis[J].Current Opinion in Infectious Diseases,2006,19:231-236
[16]Das UN.Pyruvate is an endogenous anti-inflammatory and anti- oxidant molecule[J].Med Sci Monit,2006,12(5):79-84
[17]杨智勇,王春友,陶京等.丙酮酸乙酯对重症急性胰腺炎大鼠血清高迁移率蛋白水平的影响及意义[J].中华实验外科杂志,2004,21(11):1306-1308
[18]Ulloa L,Ochani M,Yang H,et al.Ethylpyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation[J].Proc Natl Acad Sci,2002,99(19):12351-12356
[19]Sims CA,Wattanasirichaigoon S,Menconi MJ,et al.Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion induced intestinal mucosal injury in rats[J].Crit Care Med,2001,29:1513-1518
[20]Dobsak P,Courderot-Masuyer C,Zeller M,et al.Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia[J].J Cardiovasc Pharmacol,1999,34:651-659
[21]Song M,Kellum JA,Kaldas H.Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured lipopolysaccharide-stimulated RAW 264.7 cells[J].J Pharmacol Exp Ther,2004,308:307-316
[22]Uchiyama T,Delude RL,Fink MP.Dose-dependent effects of ethyl pyruvate in mice subjected to mesenteric ischemia and reperfusion[J]. Intensive Care Med,2003,29:2050-2058
[23]Woo YJ,Taylor MD,Cohen JE,et al.Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia[J].J Thorac Cardiovasc Surg,2004,127:1262-1269
[24]Yang R,Han X,Delude RL,et al.Ethyl pyruvate ameliorates acute alcohol-induced liver injury and inflammation in mice[J].J Lab Clin Med,2003,142:322-331
[25]Miyaji T,Hu X,Yuen PS,et al.Ethyl pyruvate decreases sepsis- induced acute renal failure and multiple organ damage in aged mice[J]. Kidney Int,2003,64:1620-1631
[26]Yang R,Uchiyama T,Alber SM,et al.Ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis [J].Crit Care Med,2004,32:1453-1459
[27]Sappington PL,Han X,Yang R,et al.Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immuno- stimulated caco-2 enterocytic monolayers[J].J Pharmacol Exp Ther,2003, 304:464-476
[28]Venkataraman R,Kellum JA,Song M,et al.Resuscitation with Ringer's ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide- induced shock[J].Shock,2002,18:507-512
[29]Allan Tsung,Takashi Kaizu,Atsunori Nakao,et al.Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptosis[J].Transplantation,2005,79(2):196-204
[1]Angus DC,Linde-Zwirble WT,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care[J].Crit Care Med,2001,29:1303-1310
[2]Wang HC,Bloom O,Zhang MH,et al.HMG-1 as a late mediator of endotoxin lethality in mice[J].Science,1999,285:248-251
[3]Fang Wenhui,Yao Yongming,Shi Zhiguo,et al.The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury[J].Shock,2002,17:329-333
[4]Wang H,Li W,Li J,et al.The aqueous extract of a popular herbal nutrient supplement,Angelica sinensis,protects mice against lethal endotoxemia and sepsis[J].J Nutr,2006,136(2):360-365
[5]Lin X,Yang H,SakuragiT,et al.Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis[J].Am J Physiol Lung Cell Mol Physiol,2005,289(4):583-590
[6]Sunden-Cullberg J,Norrby-Teglund A,Treutiger CJ.The role of high mobility group box-1 protein in severe sepsis[J].Current Opinion in Infectious Diseases,2006,19:231-236
[7]Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM College of Chest Physicians Society of Critical Care M edicine [J]. Chest,1992,101:1644-1655
[8]Avery BN,John CM.Sepsis,SIRS,and MODS: what′s in a name[J].World J Surg,1996,20:386-391
[9]Levy MM,Fink MP,Marshall JC,et al.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J].Crit Care Med,2003,31: 1250-1256
[10]陈孝平主编.外科学[M].第一版.北京:人民卫生出版社,2004,687-688
[11]Christian BB,Jean C,Pierre D,et al.Incidence,risk factors,and outcome of severe sepsis and septic shock in adults[J].JAMA,1995,274:968-974
[12]Alexandre P,Guillaume M,Nicolas V,et al.Longitudinal study of cytokine andimmune transcription factor mRNA expression in septic shock[J]. Clinical Immunology,2005,114:61-69
[13]Mesters R,Helterbrand J,Utterback B G,et al.Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications[J].Crit Care Med,2000,28(7):2209-2216
[14]Ombrellino M,Wang H,Ajemian MS,et al.Increased serum concentration of high-mobility-group protein 1 in haemorrhagic shock[J].Lancet , 1999 ,354(9188):1446-1447
[15]Hatada T,Wada H,Nobori T,et al.Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation[J].Thromb Haemost J,2005,94(5):975-979
[16]Lin X,Yang H,Sakuragi T,et al.Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis[J].Am J Physiol Lung Cell Mol Physiol,2005,289(4):583-590
[17]Gong JP,Liu CA,Wu CX,et al.Nuclear factor kB activity in patients with acute severe cholangitis[J].World J Gastroentero,2002,8:346-349
[18]Gong JP,Wu CX,Liu CA,et al.Liver sinusoidal endothelial cell injury by neutrophils in rats with acute obstructive cholangitis[J].World J Gastroenterol,2002,8:342-345
[19]Li SW,Gong JP,Wu CX,et al.Lipopolysaccharide induced svnthesis of CD14 protein and its gene expression in hepatiocytes during endotoxemia[J].World J Gastroenterol,2002,8:124-127
[20]李生伟,吴传新,龚建平等.内毒素上调肝细胞表达 CD14 基因和蛋白的实验研究[J].中华肝脏病杂志,2001,9:103-104,119
[21]龚建平,徐明清,韩本立等.内毒素血症时肝组织中脂多糖受体 CD14 的表达及其意义[J].中华肝胆外科杂志,2002,8:175-178
[22]Bin Tu,Jian-Ping Gong,Hu-Yi Feng,et al.Role of NF-kB in multiple organ dysfunction during actue obstructive cholangitis[J].World J Gastroenterol,2003,9(1):179-183
[23]吴传新,龚建平,刘海忠等.磷脂酰肌醇特异性磷脂酶 C 对内毒素介导枯否细胞激活的抑制作用[J].中国急救医学,2005,25(9):648-650
[24]孙 航,吴传新,龚建平等.维生素 D3 诱导的 U937 细胞中 CD14 表达[J].细胞与分子免疫学杂志,2005,21(2):155-158
[25]孙 航,吴传新,龚建平等.磷脂酰肌醇特异性磷脂酶 C 对内毒素血症大鼠肝组织 CD14 表达的抑制作用[J].基础医学与临床,2005,25(4):337-340
[26]Muller S,Ronfani L,Bianchi ME.Regulated expression and subcellular localization of HMGB1,a chromatin protein with a cytokine function[J].J Intern Med,2004,255:332-343
[27]Fang Wenhui,Yao Yongming,Shi Zhiguo,et al.The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury[J].Shock,2002,17:329-333
[28]方文慧,姚咏明,施志国等.严重烫伤后高迁移率族蛋白-1 基因表达的改变及意义[J].中华外科杂志,2001,39:137-140
[29]李红云,姚咏明,施志国等.高迁移率族蛋白-1 在烫伤后金黄色葡萄球菌脓毒症中的改变与意义[J].中华实验外科杂志,2001,18:239-241
[30]姚咏明,张立天,陆家齐等.脓毒症大鼠内毒素增敏系统改变与高迁移率族蛋白-1 表达的关系[J].中华创伤杂志,2002,18:540-543
[31]王松柏,姚咏明,董宁等.JAK/STAT 通路介导脓毒症大鼠肝组织高迁移率族蛋白 B1mRNA 表达的研究[J].中国危重病急救医学,2003,15(3):147-149
[32]张立天,姚咏明,陆家齐等.脓毒症大鼠高迁移率族蛋白-1 基因表达及其与内毒素血症的关系[J].中华普通外科杂志,2002,17:556-558
[33]Li W,Sama AE,Wang H.Role of HMGB1 in cardiovascular diseases[J].Curr Opin Pharmacol,2006,6(2):130-135
[34]Liu S,Stolz DB,Sappington PL,et al.HMGB1 is secreted by immuno- stimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers[J].Am J Physiol Cell Physiol,2006,290(4):990-999
[1]Angus DC,Linde-Zwirble WT,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care[J].Crit Care Med,2001,29:1303-1310
[2]Martin GS,ManninoDM,EatonS,et al.The epidemiology of sepsis in the United States from 1979 through 2000[J].N Engl J Med,2003,348:1546-1554
[3]Tracey KJ,Beutler B,Lowry SF,et al.Shock and tissue injury induced by recombinant human cachectin[J].Science,1986,234(4775):470-474
[4]Dinarello CA.The interleukin-1 family: 10 years of discovery[J]. FASEB J,1994,8(15):1314-1325
[5]Moldawer LL.Biology of proinflammatory cytokines and their antagonists[J].CritCare Med,1994,22(7):3-7
[6]Michie HR,Spriggs DR,Manogue KR,et al.Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings[J].Surgery,1988,104:280-286
[7]Michie HR,Manogue KR,Spriggs DR,et al.Detection of circulating tumor necrosis factor after endotoxin administration[J].N Engl J Med,1988,318:1481-1486
[8]Beutler B,Milsark IW,Cerami AC.Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin[J].Science,1985,229:869-871
[9]Tracey KJ,Fong Y,Hesse DG,et al.Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia[J].Nature,1987,330:662-664
[10]Reinhart K,Karzai W.Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned[J].Crit Care Med,2001,29(Suppl):121-125
[11]Eskandari MK,Bolgos G,Miller C,et al.Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia[J].J Immunol,1992,148:2724-2730
[12]Wang H,Yang H,Tracey KJ.Extracellular role of HMGB1 in inflammation and sepsis[J].J Intern Med,2004,255(3):320-331
[13]姚咏明,盛志勇.高迁移率族蛋白-1在脓毒症发病中的作用与意义[J].解放军医学杂志,2002,27(9):753-756
[14]Wang H,Ward MF,Fan XG,et al.Potential role of high mobility group box 1 in viral infectious diseases[J].Viral Immunol,2006,19(1):3-9
[15]Mantell LL,Parris WR,Ulloa L.Hmgb-1 as a therapeutic target for infectious and inflammatory disorders[J].Shock,2006,25(1):4-11
[16]Bustin M.Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins[J].Mol Cell Biol,1999,19:5237-5246
[17]Agresti A,Bianchi ME.HMGB proteins and gene expression[J].Curr Opin Genet Dev,2003,13:170-178
[18]Paonessa G,Frank R,Cortese R.Nucleotide sequence of rat liver HMG1 cDNA[J].Nucleic Acids Res,1987,15:9077
[19]Wen L,Huang JK,Johnson BH,et al.A human placental cDNA clone that encodesnonhistone chromosomal protein HMG-1[J].Nucleic Acids Res,1989,17:1197-1214
[20]Rauvala H,Merenmies J,Pihlaskari R,et al.The adhesive and neuri- tepromoting molecule p30:analysis of the amino-terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons[J].J Cell Biol,1988,107: 2293-2305
[21]Ferrari S,Finelli P,Rocchi M,et al. The active gene that encodes human high mobility group 1 protein(HMG1) contains introns and maps to chromosome 13[J].Genomics,1996,35:367-371
[22]Li J,Kokkola R,Tabibzadeh S,et al.Structural basis for the proinflammatory cytokine activity of high mobility group box 1[J].Mol Med, 2003,9:37-45
[23]Yang H,Tracey KJ.High mobility group box 1(HMGB1)[J].Crit Care Med,2005,33(12 Suppl):472-474
[24]Muller S,Ronfani L,BianchiME.Regulated expression and subcellular localization of HMGB1,a chromatin protein with a cytokine function[J].J Intern Med,2004,255:332-343
[25]Seyedin SM,Pehrson JR,Cole RD.Loss of chromosomal high mobility group proteins HMG1 and HMG2 when mouse neuroblastoma and Friend erythroleukemia cells become committed to differentiation[J].Proc Natl Acad Sci U S A,1981,78:5988-5992
[26]Hori O,Brett J,Slattery T,et al.The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system[J].J Biol Chem,1995,270:25752-25761
[27]Huttunen HJ,Fages C,Rauvala H.Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways[J].J Biol Chem,1999,274:19919-19924
[28]Riuzzi F,Sorci G,Donato R.The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation,apoptosis,adhesiveness,migration,and invasiveness. Functional inactivation of RAGE in L6myoblasts results in tumor formation in vivo[J].J Biol Chem , 2006 ,281(12):8242-8253
[29]Calogero S,Grassi F,Aguzzi A,et al.The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice[J].Nat Genet,1999,22:276-280
[30]Melvin VS,Edwards DP.Coregulatory proteins in steroid hormone receptor action:the role of chromatin high mobility group proteins HMG-1 and-2[J].Steroids,1999,64:576-586
[31]Melvin VS,Roemer SC,Churchill ME,et al.The C-terminal extension (CTE) of the nuclear hormone receptor DNA binding domain determines interactions and functional response to the HMGB-1/-2 co-regulatory proteins[J].J BiolChem,2002,277:25115-25124
[32]Jayaraman L,Moorthy NC,Murthy KG,et al.High mobility group protein-1 (HMG-1) is a unique activator of p53[J].Genes Dev,1998,12: 462-472
[33]Agrawal A,Schatz DG.RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination[J]. Cell,1997,89:43-53
[34]He Q,Liang CH,Lippard SJ.Steroid hormones induce HMG1 over- expression and sensitize breast cancer cells to cisplatin and carboplatin [J].Proc Natl Acad Sci U S A,2000,97:5768-5772
[35]Sapojnikova N,Maman J,Myers FA,et al.Biochemical observation of the rapid mobility of nuclear HMGB1[J].Biochim Biophys Acta,2005,1729(1):57-63
[36]Falciola L,Spada F,Calogero S,et al.High mobility group 1 protein is not stably associated with the chromosomes of somatic cells[J].J Cell Biol,1997,137:19-26
[37]Rouhiainen A,Imai S,Rauvala H,et al.Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation[J].Thromb Haemost,2000,84:1087-1094
[38]Parkkinen J,Raulo E,Merenmies J,et al.Amphoterin,the 30-kDa protein in a family of HMG1-type polypeptides.Enhanced expression in transformed cells,leading edge localization,and interactions with plasminogen activation[J].J BiolChem,1993,268:19726-19738
[39]Sparatore B,Pedrazzi M,Passalacqua M,et al.Stimulation of erythroleukaemia cell differentiation by extracellular high-mobility group-box protein 1 is independent of the receptor for advanced glycation end-products[J].Biochem J,2002,363:529-535
[40]Bonaldi T,Talamo F,Scaffidi P,et al.Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion[J]. EMBO J,2003,22:5551-5560
[41]Wolffe A P.Architectural transcription factors[J].Science,1994,264:1100-1101
[42]Gardella S,Andrei C,Ferrera D,et al.The nuclear protein HMGB1 is secreted by monocytes via a non-classical,vesicle-mediated secretory pathway[J].EMBO Rep,2002,3:995-1001
[43]Wang H,Vishnubhakat JM,Bloom O,et al.Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes[J].Surgery,1999,126:389-392
[44]Sparatore B,Patrone M,Passalacqua M,et al.Extracellular processing of amphoterin generates a peptide active on erythroleukaemia cell differentiation[J].Biochem J,2001,357:569-574
[45]Sass G,Heinlein S,Agli A,et al.Cytokine expression in three mouse models of experimental hepatitis[J].Cytokine,2002,19:115-120
[46]Fang WH,Yao YM,Shi ZG,et al.The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury[J]. Shock,2002,17:329-333
[47]Scaffidi P,Misteli T,Bianchi ME.Release of chromatin protein HMGB1 by necrotic cells triggers inflammation[J].Nature,2002,418:191-195
[48]Schmidt AM,Yan SD,Yan SF,et al.The biology of the receptor for advanced glycation end products and its ligands[J].Biochim Biophys,Acta,2000,1498:99-111
[49]Taguchi A,Blood DC,Del Toro G,et al.Blockade of RAGE-amphoterin signaling suppresses tumour growth and metastases[J].Nature,2000,405: 354-360
[50]Degryse B,Bonaldi T,Scaffidi P,et al.The high mobility group (hmg) boxes of the nuclear protein hmg1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells[J].J Cell Biol,2001,152: 1197-1206
[51]Stern D,Yan SD,Yan SF,et al.Receptor for advanced glycation endproducts:a multiligand receptor magnifying cell stress in diverse pathologic settings[J].Adv Drug Deliv Rev,2002,54(12):1615-1625
[52]Mistry AR,Falciola L,Monaco L,et al.Recombinant HMG1 protein produced in Pichia pastoris:a nonviral gene delivery agent[J]. Biotechniques,1997,22:718-729
[53]Treutiger CJ,Mullins GE,Johansson AS,et al.High mobility group 1 B-box mediates activation of human endothelium[J].J Intern Med,2003, 254:375-385
[54]Palumbo R,Sampaolesi M,De Marchis F,et al.Extracellular HMGB1,a signal of tissue damage,induces mesoangioblast migration and proliferation[J].J Cell Biol,2004,164:441-449
[55]Park JS,Svetkauskaite D,He Q,et al.Involvement of TLR 2 and TLR 4 in cellular activation by high mobility group box 1 protein (HMGB1)[J]. J Biol Chem,2004,279:7370-7377
[56]Andersson U,Wang H,Palmblad K,et al.High mobility group 1 protein (HMG-1)stimulates pro-inflammatory cytokine synthesis in human monocytes [J].J Exp Med 2000,192:565-570
[57]Park JS,Arcaroli J,Yum HK,et al.Activation of gene expression in human neutrophils by high mobility group box 1 protein[J].Am J Physiol Cell Physiol,2003,284:870-879
[58]Fiuza C,Bustin M,Talwar S,et al.Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells[J].Blood,2003,101: 2652-2660
[59]Abraham E,Arcaroli J,Carmody A,et al.HMG-1 as a mediator of acute lung inflammation[J].J Immunol,2000,165:2950-2954
[60]Pullerits R,Jonsson IM,Verdrengh M,et al.High mobility group box chromosomal protein 1,a DNA binding cytokine,induces arthritis[J]. Arthritis Rheum,2003,48:1693-1700
[61]Zetterstrom CK,Bergman T,Rynnel-Dagoo B,et al.High mobility group box chromosomal protein 1 (HMGB1) is an antibacterial factor produced by the human adenoid[J].Pediatr Res,2002,52:148-154
[62] Bustin M.Regulation of DNA-dependent activities by the functional motifs of thehigh-mobility-group chromosomal proteins[J].Mol Cell Biol,1999,19:5237-5246
[63]Read CM,Cary PD,Crane-Robinson,et al.Solution structure of a DNA- binding domain from HMG1[J].Nucleic Acids Res,1993,21:3427-3436
[64]Weir HM,Kraulis PJ,Hill CS,et al.Structure of the HMG box motif in the Bdomain of HMG1[J].EMBO J,1993,12:1311-1319
[65]Li J,Kokkola R,Tabibzadeh S,et al.Structural basis for the proinflammatory cytokine activity of high mobility group box 1[J].Mol Med,2003,9:37-45
[66]Yang H,Ochani M,Li J,et al.Reversing established sepsis with antagonists of endogenous high-mobility group box 1[J].Proc Natl Acad Sci U S A,2004,101:296-301
[67]Ombrellino M,Wang H,Ajemian MS,et al.Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock[J]. Lancet , 1999 ,354:1446-1447
[68]Hatada T,Wada H,Nobori T,et al.Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation[J].Thromb Haemost J,2005,94(5):975-979
[69]Sunden-Cullberg J,Norrby-Teglund A,Treutiger CJ.The role of high mobility group box-1 protein in severe sepsis[J].Current Opinion in Infectious Diseases,2006,19:231-236
[70]O’Connor KA,Hansen MK,Rachal Pugh C,et al.Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine:central nervous system effects[J].Cytokine,2003,24:254-265
[71]Kokkola R,Sundberg E,Ulfgren AK,et al.High mobility group box chromosomal protein 1:a novel proinflammatory mediator in synovitis[J]. Arthritis Rheum,2002,46:2598-2603
[72]Taniguchi N,Kawahara K,Yone K,et al.High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine[J].Arthritis Rheum,2003,48:971-981
[73]Popovic K , Ek M , Espinosa A , et al.Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skinlesions of patients with lupus erythematosus[J].Arthritis Rheum , 2005 ,52(11):3639-3645
[74]Ulfgren AK,Grundtman C,Alexandersson H,et al.Cortocosteroid- therapy downregulates the proinflammatory mediator HMGB1 in myositis patients[J].Arthritis Rheum,2004,Inpress
[75]王松柏,姚咏明,董宁等.JAK/STAT通路介导脓毒症大鼠肝组织高迁移率族蛋白B1 mRNA表达的研究[J].中国危重病急救医学,2003,15(3):147-149
[76]Yang H,Wang H,Czura CJ,et al.HMGB1 as a cytokine and therapeutic target[J].J Endotoxin Res,2002,8(6):469-472
[77]Yin K,Gribbin E,Wang H.Interferon-gamma inhibition attenuates lethality after cecal ligation and puncture in rats:implication of high mobility group box-1[J].Shock,2005,24(4):396-401
[78]Andersson U,Wang H,Palmblad K,et al.High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes[J].J Exp Med,2000,192(4):565-570
[79]Liu S,Stolz DB,Sappington PL,et al.HMGB1 is secreted by immuno- stimulated enterocytes and contributes to cytomix-induced hyperper- meability of Caco-2 monolayers[J].Am J Physiol Cell Physiol,2006, 290(4):990-999
[80]Sappington PL,Yang R,Yang H,et al.HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice[J].Gastroenterology,2002,123:790-802
[81]Sanford AN,Dietzmann K,Sullivan KE.Apoptotic cells, autoantibodies,and the role of HMGB1 in the subcellular localization of an autoantigen[J].J Autoimmun,2005,25(4):264-271
[82]Dumitriu IE,Baruah P,Manfredi AA,et al.HMGB1: guiding immunity from within[J].Trends Immunol,2005,26(7):381-387
[83]Remick D,Manohar P,Bolgos G,et al.Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture[J].Shock,1995,4:89-95
[84]Calandra T,Echtenacher B,Roy DL,et al.Protection from septic shock byneutralization of macrophage migration inhibitory factor[J].Nat Med , 2000 ,6:164-170
[85]Kokkola R,Li J,Sundberg E,et al.Successful treatment of collagen- induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity[J].Arthritis Rheum,2003,48:2052-2058
[86]Ulloa L,Ochani M,Yang H,et al.Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation[J].Proc Natl Acad Sci U S A,2002,99:12351-12356
[87]Yang R,Gallo DJ,Baust JJ,et al.Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock[J]. Am J Physiol Gastrointest Liver Physiol,2002,283:212-221
[88]Das UN.Pyruvate is an endogenous anti-inflammatory and anti-oxidant molecule[J].Med Sci Monit,2006,25,12(5):79-84
[89]Riedemann NC,Guo RF,Ward PA.Novel strategies for the treatment of sepsis [J].Nat Med,2003,9(5):517-524
[2] Martin GS,Mannino DM,Eaton S,et al. The epidemiology of sepsis in the United States from 1979 through 2000[J].N Engl J Med,2003,348(16):1546-1554
[3] Tracey KJ,Beutler B,Lowry SF,et al. Shock and tissue injury induced by recombinant human cachectin[J]. Science,1986,234(4775):470-474
[4]Dinarello CA. The interleukin-1 family:10 years of discovery[J].FASEB J,1994,8(15):1314-1325
[5] Moldawer LL. Biology of proinflammatory cytokines and their antagonists[J]. Crit Care Med,1994,22(7):3-7
[6] Michie HR,Spriggs DR,Manogue KR,et al. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings[J]. Surgery,1988,104(2):280-286
[7] Michie HR,Manogue KR,Spriggs DR,et al. Detection of circulating tumor necrosis factor after endotoxin administration[J]. N Engl J Med,1988,318(23):1481-1486
[8] Beutler B,Milsark IW,Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin[J]. Science,1985,229(4716):869-871
[9] Tracey K J,Beutler B,Lowry SF,et al. Shock and tissue injury induced by recombinant human cachectin[J]. Science,1986,234(4775):470-474
[10]Tracey KJ,Fong Y,Hesse DG,et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia[J]. Nature, 1987,330(6149): 662-664
[11]Reinhart K,Karzai W. Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned[J]. Crit Care Med,2001,29(Suppl.):121-125
[12]Eskandari MK,Bolgos G,Miller C,et al. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia[J]. JImmunol,1992,148(9):2724-2730
[13]Marino MW,Dunn A,Grail D,et al. Characterization of tumor necrosis factor-deficient mice[J]. Proc Natl Acad Sci USA,1997,94(15): 8093-8098
[14]Wang HC,Bloom O,Zhang MH,et al. HMG-1 as a late mediator of endotoxin lethality in mice[J]. Science,1999,285(5425):248-251
[15]Wang H,Li W,Li J,et al. The aqueous extract of a popular herbal nutrient supplement,Angelica sinensis,protects mice against lethal endotoxemia and sepsis[J]. J Nutr,2006,136(2):360-365
[16]Lin X,Yang H,Sakuragi T,et al. Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis[J]. Am J Physiol Lung Cell Mol Physiol,2005,289(4):583-590
[17]Sunden-Cullberg J,Norrby-Teglund A,Treutiger CJ. The role of high mobility group box-1 protein in severe sepsis[J]. Curr Opin Infect Dis,2006,19(3):231–236
[18]Bustin M. Revised nomenclature for high mobility group (HMG)chromosomal proteins[J]. Trends Biochem Sci,2001,26(3):152-153
[19]Thomas J O. HMG1 and 2:architectural DNA-binding proteins[J].Biochem Soc Trans,2001,29(4):395-401
[20]Bonaldi T,Langst G,Strohner R,et al. The DNA chaperond HMGB1 facilitates ACF/CHRAC-dependent nucleosome sliding[J]. EMBO J,2002,21(24):6865-6873
[21]Christopher JC,Huan Yang,Kevin JT. High mobility group box-1 as a therapeutic target downstream of tumor necrosis factor[J]. J Infect Dis,2003,187(Suppl 2):S391-396
[22]Treutiger CJ,Mullins GE,Johansson AS,et al. High mobility group 1 B-box mediates activation of human endothelium[J]. J Intern Med,2003,254(4):378-385
[23]Fiuza C,Bustin M,Talwar S,et al. Inflammatory promoting activity of HMGB1 on human microvascular endothelial cells[J]. Blood,2003,101(7):2652-2660
[24]Pachot A,Monneret G,Voirin N,et al. Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock[J]. Clinical Immunology,2005,114(1):61-69
[25]Harris HE,Andersson U. The nuclear protein HMGB1 as a proinflammatory mediator[J]. Eur J Immunol,2004,34(6):1503-1512
[26]Tang D,Shi Y,Jang L,et al. Heat shock response inhibits release of high mobility group box 1 protein induced by endotoxin in murine macrophages[J]. Shock,2005,23(5):434-440
[27]Lin X,Yang H,Sakuragi T,et al. Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis[J]. Am J Physiol Lung Cell Mol Physiol,2005,289(4):583-590
[28]Yin K,Gribbin E,Wang H. Interferon-gamma inhibition attenuates lethality after cecal ligation and puncture in rats: implication of high mobility group box-1[J]. Shock,2005,24(4):396-401
[29]Mantell LL,Parris WR,Ulloa L. Hmgb-1 as a therapeutic target for infectious and inflammatory disorders[J]. Shock,2006,25(1):4-11
[30]Chen X,Li W,Wang H. More tea for septic patients?--Green tea may reduce endotoxin-induced release of high mobility group box 1 and other pro-inflammatory cytokines[J]. Med Hypotheses,2006,66(3):660-663
[31]Das UN. Pyruvate is an endogenous anti-inflammatory and anti-oxidant molecule[J]. Med Sci Monit,2006,12(5):79-84
[32]Ulloa L,Ochani M,Yang H,et al. Ethylpyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation[J]. Proc Natl Acad Sci,2002,99(19):12351-12356
[33]Allan Tsung,Takashi Kaizu,Atsunori Nakao,et al. Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptosis[J]. Transplantation,2005,79(2):196-204
[34]Yang R,Uchiyama T,Watkins SK,et al. Ethyl pyruvate reduces liver injury in a murine model of extrahepatic cholestasis[J]. Shock,2004,22(4):369-375
[35]Yang R,Uchiyama T,Alber SM,et al.Ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis[J]. Crit Care Med,2004,32(7):1453-1459
[36]Alexandre P,Guillaume M,Nicolas V,et al. Longitudinal study of cytokine andimmune transcription factor mRNA expression in septic shock[J]. Clin Immuno,2005,114(1):61-69
[37]Beatriz RM,Mahendar O,Jianhua Li,et al. IFN-γ induces high mobility group Box 1 protein release partly through a TNF-dependent mechanism[J]. J Immuno,2003,170(7):3890–3897
[1]Angus DC,Linde-Zwirble WT,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care[J].Crit Care Med,2001,29:1303-1310
[2]Tracey KJ,Beutler B,Lowry SF,et al.Shock and tissue injury induced by recombinant human cachectin[J].Science,1986,234(4775):470-474
[3]Dinarello CA.The interleukin-1 family: 10 years of discovery[J]. FASEB J,1994,8(15):1314-1325
[4]Moldawer LL.Biology of proinflammatory cytokines and their antagonists[J].Crit Care Med,1994,22(7):3-7
[5]Beutler B,Milsark IW,Cerami AC.Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin[J].Science,1985,229:869-871
[6]Tracey K J,Beutler B,Lowry SF,et al.Shock and tissue injury induced by recombinant human cachectin[J].Science,1986,234:470-474
[7]Tracey KJ,Fong Y,Hesse DG,et al.Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia[J].Nature,1987,330:662-664
[8]Reinhart K,Karzai W.Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned[J].Crit Care Med,2001,29(Suppl):121-125
[9]Eskandari MK,Bolgos G,Miller C,et al.Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia[J].J Immunol,1992,148:2724-2730
[10]Beatriz RM,Mahendar O,Jianhua Li,et al.IFN-γ induces high mobility group Box 1 protein release partly through a TNF-dependent mechanism[J].The Journal of Immunology,2003,170:3890-3897
[11]Bustin M,Reeves R.High mobility group chrosomosomal proteins: architectural components that facilitate chromatin function[J].Prog Nucleic Acid Res Mol Biol,1996,54:35-100
[12]Melvin VS,Edwards DP.Coregulatory proteins in steroid hormone receptor action:the role of chromatin high mobilitygroup proteins HMGB-1 and-2[J].Steroids,1999,64:576-586
[13]Bustin M.Revised nomenclature for high mobility group (HMG) chromosomal proteins[J].Trends Biochem Sci,2001,26(3):152-153
[14]Thomas JO.HMG1 and 2:architectural DNA-binding proteins[J]. Biochem Soc Trans,2001,29(4):395-401
[15]Bonaldi T,Langst G,Strohner R,et al.The DNA chaperond HMGB1 facilitates ACF/CHRAC-dependent nucleosome sliding[J].EMBO J,2002,21(24): 6865-6873
[16]Sun NK,Chao CC.The cytokine activity of HMGB1--extracellular escape of the nuclear protein[J].Chang Gung Med J,2005,28(10):673-682
[17]Sapojnikova N,Maman J,Myers FA,et al.Biochemical observation of the rapid mobility of nuclear HMGB1[J].Biochim Biophys Acta,2005,1729(1):57-63
[18]Li W,Sama AE,Wang H.Role of HMGB1 in cardiovascular diseases[J]. Curr Opin Pharmacol,2006,6(2):130-135
[19]Merenmies J,Pihlaskari R,Laitinen J,et al.30-kDa heparin-binding protein of brain (amphoterin)involved in neurite outgrowth:amino acid sequence and localization in the filopodia of the advancing plasma membrane[J].J Biol Chem , 1991 ,266:16722-16729
[20]Daston MM,Ratner N.Expression of p30,a protein with adhesive properties,in Schwann cells and neurons of the developingand regenerating peripheral nerve[J].J Cell Biol,1991,112:1229-1239
[21]Parkkinen J,Rauvala H.Interactions of plasmingenand tissue plasmingen avtivator (t-PA) with amphoterin[J].J BiolChem,1991,266:16730-16735
[22]Brickman JM,Adam M,Ptashine M.Interactionsbetween an HMGB1 protein and members of the Rel family[J].Proc Natl Acad Sci USA,1999,96:10679- 10683
[23]Wang HC,Bloom O,Zhang MH,et al.HMG-1 as a late mediator of endotoxin lethality in mice[J].Science,1999,285:248-251
[24]Fang Wenhui,Yao Yongming,Shi Zhiguo,et al.The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury[J].Shock,2002,17:329-333
[25]Wang H,Li W,Li J,et al.The aqueous extract of a popular herbal nutrientsupplement,Angelica sinensis,protects mice against lethal endotoxemia and sepsis[J].J Nutr,2006,136(2):360-365
[26]Lin X,Yang H,Sakuragi T,et al.Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis[J].Am J Physiol Lung Cell Mol Physiol,2005,289(4):583-590
[27]Sunden-Cullberg J,Norrby-Teglund A,Treutiger CJ.The role of high mobility group box-1 protein in severe sepsis[J].Current Opinion in Infectious Diseases,2006,19:231-236
[28]Christopher JC,Huan Yang,Kevin JT.High mobility group box-1 as a therapeutic target downstream of tumor necrosis factor[J].The Journal of Infectious Diseases,2003,187(supple2):391-396
[29]Treutiger CJ,Mullins GE,Johansson AS,et al.High mobility group 1 B-box mediates activation of human endothelium[J].J Intern Med,2003,254:378-385
[30]Fiuza C,Bustin M,Talwar S,et al.Inf lammatory promoting activity of HMGB1 on human microvascular endothelial cells[J].Blood,2003,101: 2652-2660
[31]Pachot A,Monneret G,Voirin N,et al.Longitudinal study of cytokine and immune transcription factor mRNA expression in septic shock[J]. Clinical Immunology,2005,114:61-69
[32]Harris HE,Andersson U.The nuclear protein HMGB1 as a pro- inflammatory mediator[J].Eur J Immunol,2004,34:1503-1512
[33]Widmann C,Gibson S,Jarpe MB,et al.Mitogen activated protein kinase: conservation of a three-kinase module from yeast to human[J].Physiol Rev,1999,79(1):143-180
[34]Yang RB , Mark MR , Gurney AL , et al.Signaling events induced by lipopolysaccharide-activated toll-like receptor 2[J].J Immunol , 1999 , 163(2):639-643
[35]Baldwin AS.The NF-kappa B and I kappa B proteins: new discoveries and insights[J].Annu Rev Immunol,1996,14:649-683
[36]O’Neill LA.The role of MyD88-like adapters in Toll-like receptor signal transduction[J].Biochem Soc Trans,2003,31:643-647
[37]Harris HE,Andersson U.The nuclear protein HMGB1 as a pro- inflammatory mediator[J].Eur J Immunol,2004,34:1503-1512
[38]Gardella S,Andrei C,Ferrera D,et al.The nuclear protein HMGB1 is secreted by monocytes via a non-classical,vesicle-mediated[J].EMBO Rep,2002,3:995-1001
[39]Bonaldi T,Talamo F,Scaffidi P,et al.Monocytic cells hyEPracetylate chromat in protein HMGB1 to redirect it towards secretion[J].The EMBO Journal,2003,22(20):5551-5560
[1]Tracey KJ,Beutler B,Lowry SF,et al.Shock and tissue injury induced by recombinant human cachectin[J].Science,1986,234(4775):470-474
[2]Dinarello CA.The interleukin-1 family: 10 years of discovery [J].FASEB J,1994,8(15):1314-1325
[3]Moldawer LL.Biology of proinflammatory cytokines and their antagonists[J].Crit Care Med,1994,22(7):3-7
[4]Michie HR,Spriggs DR,Manogue KR,et al.Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings[J].Surgery,1988,104:280-286
[5]Michie HR,Manogue KR,Spriggs DR,et al.Detection of circulating tumor necrosis factor after endotoxin administration[J].N Engl J Med,1988,318:1481-1486
[6]Beutler B,Milsark IW,Cerami AC.Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin[J].Science,1985,229:869-871
[7]Tracey K J,Beutler B,Lowry SF,et al.Shock and tissue injury induced by recombinant human cachectin[J].Science,1986,234:470-474
[8]Tracey KJ,Fong Y,Hesse DG,et al.Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia[J].Nature, 1987,330:662-664
[9]Reinhart K,Karzai W.Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned[J].Crit Care Med,2001,29(Suppl):121-125
[10]Eskandari MK,Bolgos G,Miller C,et al.Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia[J].J Immunol,1992,148:2724-2730
[11]Wang HC,Bloom O,Zhang MH,et al.HMG-1 as a late mediator of endotoxin lethality in mice[J].Science,1999,285:248-251
[12]Fang Wenhui,Yao Yongming,Shi Zhiguo,et al.The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury[J].Shock,2002,17:329-333
[13] Wang H,Li W,Li J,et al.The aqueous extract of a popular herbal nutrient supplement, Angelica sinensis, protects mice against lethal endotoxemia andsepsis[J].J Nutr,2006,136(2):360-365
[14]Lin X,Yang H,Sakuragi T,et al.Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis[J].Am J Physiol Lung Cell Mol Physiol,2005,289(4):583-590
[15]Sunden-Cullberg J,Norrby-Teglund A,Treutiger CJ.The role of high mobility group box-1 protein in severe sepsis[J].Current Opinion in Infectious Diseases,2006,19:231-236
[16]Das UN.Pyruvate is an endogenous anti-inflammatory and anti- oxidant molecule[J].Med Sci Monit,2006,12(5):79-84
[17]杨智勇,王春友,陶京等.丙酮酸乙酯对重症急性胰腺炎大鼠血清高迁移率蛋白水平的影响及意义[J].中华实验外科杂志,2004,21(11):1306-1308
[18]Ulloa L,Ochani M,Yang H,et al.Ethylpyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation[J].Proc Natl Acad Sci,2002,99(19):12351-12356
[19]Sims CA,Wattanasirichaigoon S,Menconi MJ,et al.Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion induced intestinal mucosal injury in rats[J].Crit Care Med,2001,29:1513-1518
[20]Dobsak P,Courderot-Masuyer C,Zeller M,et al.Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia[J].J Cardiovasc Pharmacol,1999,34:651-659
[21]Song M,Kellum JA,Kaldas H.Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured lipopolysaccharide-stimulated RAW 264.7 cells[J].J Pharmacol Exp Ther,2004,308:307-316
[22]Uchiyama T,Delude RL,Fink MP.Dose-dependent effects of ethyl pyruvate in mice subjected to mesenteric ischemia and reperfusion[J]. Intensive Care Med,2003,29:2050-2058
[23]Woo YJ,Taylor MD,Cohen JE,et al.Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia[J].J Thorac Cardiovasc Surg,2004,127:1262-1269
[24]Yang R,Han X,Delude RL,et al.Ethyl pyruvate ameliorates acute alcohol-induced liver injury and inflammation in mice[J].J Lab Clin Med,2003,142:322-331
[25]Miyaji T,Hu X,Yuen PS,et al.Ethyl pyruvate decreases sepsis- induced acute renal failure and multiple organ damage in aged mice[J]. Kidney Int,2003,64:1620-1631
[26]Yang R,Uchiyama T,Alber SM,et al.Ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis [J].Crit Care Med,2004,32:1453-1459
[27]Sappington PL,Han X,Yang R,et al.Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immuno- stimulated caco-2 enterocytic monolayers[J].J Pharmacol Exp Ther,2003, 304:464-476
[28]Venkataraman R,Kellum JA,Song M,et al.Resuscitation with Ringer's ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide- induced shock[J].Shock,2002,18:507-512
[29]Allan Tsung,Takashi Kaizu,Atsunori Nakao,et al.Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptosis[J].Transplantation,2005,79(2):196-204
[1]Angus DC,Linde-Zwirble WT,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care[J].Crit Care Med,2001,29:1303-1310
[2]Wang HC,Bloom O,Zhang MH,et al.HMG-1 as a late mediator of endotoxin lethality in mice[J].Science,1999,285:248-251
[3]Fang Wenhui,Yao Yongming,Shi Zhiguo,et al.The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury[J].Shock,2002,17:329-333
[4]Wang H,Li W,Li J,et al.The aqueous extract of a popular herbal nutrient supplement,Angelica sinensis,protects mice against lethal endotoxemia and sepsis[J].J Nutr,2006,136(2):360-365
[5]Lin X,Yang H,SakuragiT,et al.Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis[J].Am J Physiol Lung Cell Mol Physiol,2005,289(4):583-590
[6]Sunden-Cullberg J,Norrby-Teglund A,Treutiger CJ.The role of high mobility group box-1 protein in severe sepsis[J].Current Opinion in Infectious Diseases,2006,19:231-236
[7]Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM College of Chest Physicians Society of Critical Care M edicine [J]. Chest,1992,101:1644-1655
[8]Avery BN,John CM.Sepsis,SIRS,and MODS: what′s in a name[J].World J Surg,1996,20:386-391
[9]Levy MM,Fink MP,Marshall JC,et al.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J].Crit Care Med,2003,31: 1250-1256
[10]陈孝平主编.外科学[M].第一版.北京:人民卫生出版社,2004,687-688
[11]Christian BB,Jean C,Pierre D,et al.Incidence,risk factors,and outcome of severe sepsis and septic shock in adults[J].JAMA,1995,274:968-974
[12]Alexandre P,Guillaume M,Nicolas V,et al.Longitudinal study of cytokine andimmune transcription factor mRNA expression in septic shock[J]. Clinical Immunology,2005,114:61-69
[13]Mesters R,Helterbrand J,Utterback B G,et al.Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications[J].Crit Care Med,2000,28(7):2209-2216
[14]Ombrellino M,Wang H,Ajemian MS,et al.Increased serum concentration of high-mobility-group protein 1 in haemorrhagic shock[J].Lancet , 1999 ,354(9188):1446-1447
[15]Hatada T,Wada H,Nobori T,et al.Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation[J].Thromb Haemost J,2005,94(5):975-979
[16]Lin X,Yang H,Sakuragi T,et al.Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis[J].Am J Physiol Lung Cell Mol Physiol,2005,289(4):583-590
[17]Gong JP,Liu CA,Wu CX,et al.Nuclear factor kB activity in patients with acute severe cholangitis[J].World J Gastroentero,2002,8:346-349
[18]Gong JP,Wu CX,Liu CA,et al.Liver sinusoidal endothelial cell injury by neutrophils in rats with acute obstructive cholangitis[J].World J Gastroenterol,2002,8:342-345
[19]Li SW,Gong JP,Wu CX,et al.Lipopolysaccharide induced svnthesis of CD14 protein and its gene expression in hepatiocytes during endotoxemia[J].World J Gastroenterol,2002,8:124-127
[20]李生伟,吴传新,龚建平等.内毒素上调肝细胞表达 CD14 基因和蛋白的实验研究[J].中华肝脏病杂志,2001,9:103-104,119
[21]龚建平,徐明清,韩本立等.内毒素血症时肝组织中脂多糖受体 CD14 的表达及其意义[J].中华肝胆外科杂志,2002,8:175-178
[22]Bin Tu,Jian-Ping Gong,Hu-Yi Feng,et al.Role of NF-kB in multiple organ dysfunction during actue obstructive cholangitis[J].World J Gastroenterol,2003,9(1):179-183
[23]吴传新,龚建平,刘海忠等.磷脂酰肌醇特异性磷脂酶 C 对内毒素介导枯否细胞激活的抑制作用[J].中国急救医学,2005,25(9):648-650
[24]孙 航,吴传新,龚建平等.维生素 D3 诱导的 U937 细胞中 CD14 表达[J].细胞与分子免疫学杂志,2005,21(2):155-158
[25]孙 航,吴传新,龚建平等.磷脂酰肌醇特异性磷脂酶 C 对内毒素血症大鼠肝组织 CD14 表达的抑制作用[J].基础医学与临床,2005,25(4):337-340
[26]Muller S,Ronfani L,Bianchi ME.Regulated expression and subcellular localization of HMGB1,a chromatin protein with a cytokine function[J].J Intern Med,2004,255:332-343
[27]Fang Wenhui,Yao Yongming,Shi Zhiguo,et al.The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury[J].Shock,2002,17:329-333
[28]方文慧,姚咏明,施志国等.严重烫伤后高迁移率族蛋白-1 基因表达的改变及意义[J].中华外科杂志,2001,39:137-140
[29]李红云,姚咏明,施志国等.高迁移率族蛋白-1 在烫伤后金黄色葡萄球菌脓毒症中的改变与意义[J].中华实验外科杂志,2001,18:239-241
[30]姚咏明,张立天,陆家齐等.脓毒症大鼠内毒素增敏系统改变与高迁移率族蛋白-1 表达的关系[J].中华创伤杂志,2002,18:540-543
[31]王松柏,姚咏明,董宁等.JAK/STAT 通路介导脓毒症大鼠肝组织高迁移率族蛋白 B1mRNA 表达的研究[J].中国危重病急救医学,2003,15(3):147-149
[32]张立天,姚咏明,陆家齐等.脓毒症大鼠高迁移率族蛋白-1 基因表达及其与内毒素血症的关系[J].中华普通外科杂志,2002,17:556-558
[33]Li W,Sama AE,Wang H.Role of HMGB1 in cardiovascular diseases[J].Curr Opin Pharmacol,2006,6(2):130-135
[34]Liu S,Stolz DB,Sappington PL,et al.HMGB1 is secreted by immuno- stimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers[J].Am J Physiol Cell Physiol,2006,290(4):990-999
[1]Angus DC,Linde-Zwirble WT,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care[J].Crit Care Med,2001,29:1303-1310
[2]Martin GS,ManninoDM,EatonS,et al.The epidemiology of sepsis in the United States from 1979 through 2000[J].N Engl J Med,2003,348:1546-1554
[3]Tracey KJ,Beutler B,Lowry SF,et al.Shock and tissue injury induced by recombinant human cachectin[J].Science,1986,234(4775):470-474
[4]Dinarello CA.The interleukin-1 family: 10 years of discovery[J]. FASEB J,1994,8(15):1314-1325
[5]Moldawer LL.Biology of proinflammatory cytokines and their antagonists[J].CritCare Med,1994,22(7):3-7
[6]Michie HR,Spriggs DR,Manogue KR,et al.Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings[J].Surgery,1988,104:280-286
[7]Michie HR,Manogue KR,Spriggs DR,et al.Detection of circulating tumor necrosis factor after endotoxin administration[J].N Engl J Med,1988,318:1481-1486
[8]Beutler B,Milsark IW,Cerami AC.Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin[J].Science,1985,229:869-871
[9]Tracey KJ,Fong Y,Hesse DG,et al.Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia[J].Nature,1987,330:662-664
[10]Reinhart K,Karzai W.Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned[J].Crit Care Med,2001,29(Suppl):121-125
[11]Eskandari MK,Bolgos G,Miller C,et al.Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia[J].J Immunol,1992,148:2724-2730
[12]Wang H,Yang H,Tracey KJ.Extracellular role of HMGB1 in inflammation and sepsis[J].J Intern Med,2004,255(3):320-331
[13]姚咏明,盛志勇.高迁移率族蛋白-1在脓毒症发病中的作用与意义[J].解放军医学杂志,2002,27(9):753-756
[14]Wang H,Ward MF,Fan XG,et al.Potential role of high mobility group box 1 in viral infectious diseases[J].Viral Immunol,2006,19(1):3-9
[15]Mantell LL,Parris WR,Ulloa L.Hmgb-1 as a therapeutic target for infectious and inflammatory disorders[J].Shock,2006,25(1):4-11
[16]Bustin M.Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins[J].Mol Cell Biol,1999,19:5237-5246
[17]Agresti A,Bianchi ME.HMGB proteins and gene expression[J].Curr Opin Genet Dev,2003,13:170-178
[18]Paonessa G,Frank R,Cortese R.Nucleotide sequence of rat liver HMG1 cDNA[J].Nucleic Acids Res,1987,15:9077
[19]Wen L,Huang JK,Johnson BH,et al.A human placental cDNA clone that encodesnonhistone chromosomal protein HMG-1[J].Nucleic Acids Res,1989,17:1197-1214
[20]Rauvala H,Merenmies J,Pihlaskari R,et al.The adhesive and neuri- tepromoting molecule p30:analysis of the amino-terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons[J].J Cell Biol,1988,107: 2293-2305
[21]Ferrari S,Finelli P,Rocchi M,et al. The active gene that encodes human high mobility group 1 protein(HMG1) contains introns and maps to chromosome 13[J].Genomics,1996,35:367-371
[22]Li J,Kokkola R,Tabibzadeh S,et al.Structural basis for the proinflammatory cytokine activity of high mobility group box 1[J].Mol Med, 2003,9:37-45
[23]Yang H,Tracey KJ.High mobility group box 1(HMGB1)[J].Crit Care Med,2005,33(12 Suppl):472-474
[24]Muller S,Ronfani L,BianchiME.Regulated expression and subcellular localization of HMGB1,a chromatin protein with a cytokine function[J].J Intern Med,2004,255:332-343
[25]Seyedin SM,Pehrson JR,Cole RD.Loss of chromosomal high mobility group proteins HMG1 and HMG2 when mouse neuroblastoma and Friend erythroleukemia cells become committed to differentiation[J].Proc Natl Acad Sci U S A,1981,78:5988-5992
[26]Hori O,Brett J,Slattery T,et al.The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system[J].J Biol Chem,1995,270:25752-25761
[27]Huttunen HJ,Fages C,Rauvala H.Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways[J].J Biol Chem,1999,274:19919-19924
[28]Riuzzi F,Sorci G,Donato R.The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation,apoptosis,adhesiveness,migration,and invasiveness. Functional inactivation of RAGE in L6myoblasts results in tumor formation in vivo[J].J Biol Chem , 2006 ,281(12):8242-8253
[29]Calogero S,Grassi F,Aguzzi A,et al.The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice[J].Nat Genet,1999,22:276-280
[30]Melvin VS,Edwards DP.Coregulatory proteins in steroid hormone receptor action:the role of chromatin high mobility group proteins HMG-1 and-2[J].Steroids,1999,64:576-586
[31]Melvin VS,Roemer SC,Churchill ME,et al.The C-terminal extension (CTE) of the nuclear hormone receptor DNA binding domain determines interactions and functional response to the HMGB-1/-2 co-regulatory proteins[J].J BiolChem,2002,277:25115-25124
[32]Jayaraman L,Moorthy NC,Murthy KG,et al.High mobility group protein-1 (HMG-1) is a unique activator of p53[J].Genes Dev,1998,12: 462-472
[33]Agrawal A,Schatz DG.RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination[J]. Cell,1997,89:43-53
[34]He Q,Liang CH,Lippard SJ.Steroid hormones induce HMG1 over- expression and sensitize breast cancer cells to cisplatin and carboplatin [J].Proc Natl Acad Sci U S A,2000,97:5768-5772
[35]Sapojnikova N,Maman J,Myers FA,et al.Biochemical observation of the rapid mobility of nuclear HMGB1[J].Biochim Biophys Acta,2005,1729(1):57-63
[36]Falciola L,Spada F,Calogero S,et al.High mobility group 1 protein is not stably associated with the chromosomes of somatic cells[J].J Cell Biol,1997,137:19-26
[37]Rouhiainen A,Imai S,Rauvala H,et al.Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation[J].Thromb Haemost,2000,84:1087-1094
[38]Parkkinen J,Raulo E,Merenmies J,et al.Amphoterin,the 30-kDa protein in a family of HMG1-type polypeptides.Enhanced expression in transformed cells,leading edge localization,and interactions with plasminogen activation[J].J BiolChem,1993,268:19726-19738
[39]Sparatore B,Pedrazzi M,Passalacqua M,et al.Stimulation of erythroleukaemia cell differentiation by extracellular high-mobility group-box protein 1 is independent of the receptor for advanced glycation end-products[J].Biochem J,2002,363:529-535
[40]Bonaldi T,Talamo F,Scaffidi P,et al.Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion[J]. EMBO J,2003,22:5551-5560
[41]Wolffe A P.Architectural transcription factors[J].Science,1994,264:1100-1101
[42]Gardella S,Andrei C,Ferrera D,et al.The nuclear protein HMGB1 is secreted by monocytes via a non-classical,vesicle-mediated secretory pathway[J].EMBO Rep,2002,3:995-1001
[43]Wang H,Vishnubhakat JM,Bloom O,et al.Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes[J].Surgery,1999,126:389-392
[44]Sparatore B,Patrone M,Passalacqua M,et al.Extracellular processing of amphoterin generates a peptide active on erythroleukaemia cell differentiation[J].Biochem J,2001,357:569-574
[45]Sass G,Heinlein S,Agli A,et al.Cytokine expression in three mouse models of experimental hepatitis[J].Cytokine,2002,19:115-120
[46]Fang WH,Yao YM,Shi ZG,et al.The significance of changes in high mobility group-1 protein mRNA expression in rats after thermal injury[J]. Shock,2002,17:329-333
[47]Scaffidi P,Misteli T,Bianchi ME.Release of chromatin protein HMGB1 by necrotic cells triggers inflammation[J].Nature,2002,418:191-195
[48]Schmidt AM,Yan SD,Yan SF,et al.The biology of the receptor for advanced glycation end products and its ligands[J].Biochim Biophys,Acta,2000,1498:99-111
[49]Taguchi A,Blood DC,Del Toro G,et al.Blockade of RAGE-amphoterin signaling suppresses tumour growth and metastases[J].Nature,2000,405: 354-360
[50]Degryse B,Bonaldi T,Scaffidi P,et al.The high mobility group (hmg) boxes of the nuclear protein hmg1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells[J].J Cell Biol,2001,152: 1197-1206
[51]Stern D,Yan SD,Yan SF,et al.Receptor for advanced glycation endproducts:a multiligand receptor magnifying cell stress in diverse pathologic settings[J].Adv Drug Deliv Rev,2002,54(12):1615-1625
[52]Mistry AR,Falciola L,Monaco L,et al.Recombinant HMG1 protein produced in Pichia pastoris:a nonviral gene delivery agent[J]. Biotechniques,1997,22:718-729
[53]Treutiger CJ,Mullins GE,Johansson AS,et al.High mobility group 1 B-box mediates activation of human endothelium[J].J Intern Med,2003, 254:375-385
[54]Palumbo R,Sampaolesi M,De Marchis F,et al.Extracellular HMGB1,a signal of tissue damage,induces mesoangioblast migration and proliferation[J].J Cell Biol,2004,164:441-449
[55]Park JS,Svetkauskaite D,He Q,et al.Involvement of TLR 2 and TLR 4 in cellular activation by high mobility group box 1 protein (HMGB1)[J]. J Biol Chem,2004,279:7370-7377
[56]Andersson U,Wang H,Palmblad K,et al.High mobility group 1 protein (HMG-1)stimulates pro-inflammatory cytokine synthesis in human monocytes [J].J Exp Med 2000,192:565-570
[57]Park JS,Arcaroli J,Yum HK,et al.Activation of gene expression in human neutrophils by high mobility group box 1 protein[J].Am J Physiol Cell Physiol,2003,284:870-879
[58]Fiuza C,Bustin M,Talwar S,et al.Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells[J].Blood,2003,101: 2652-2660
[59]Abraham E,Arcaroli J,Carmody A,et al.HMG-1 as a mediator of acute lung inflammation[J].J Immunol,2000,165:2950-2954
[60]Pullerits R,Jonsson IM,Verdrengh M,et al.High mobility group box chromosomal protein 1,a DNA binding cytokine,induces arthritis[J]. Arthritis Rheum,2003,48:1693-1700
[61]Zetterstrom CK,Bergman T,Rynnel-Dagoo B,et al.High mobility group box chromosomal protein 1 (HMGB1) is an antibacterial factor produced by the human adenoid[J].Pediatr Res,2002,52:148-154
[62] Bustin M.Regulation of DNA-dependent activities by the functional motifs of thehigh-mobility-group chromosomal proteins[J].Mol Cell Biol,1999,19:5237-5246
[63]Read CM,Cary PD,Crane-Robinson,et al.Solution structure of a DNA- binding domain from HMG1[J].Nucleic Acids Res,1993,21:3427-3436
[64]Weir HM,Kraulis PJ,Hill CS,et al.Structure of the HMG box motif in the Bdomain of HMG1[J].EMBO J,1993,12:1311-1319
[65]Li J,Kokkola R,Tabibzadeh S,et al.Structural basis for the proinflammatory cytokine activity of high mobility group box 1[J].Mol Med,2003,9:37-45
[66]Yang H,Ochani M,Li J,et al.Reversing established sepsis with antagonists of endogenous high-mobility group box 1[J].Proc Natl Acad Sci U S A,2004,101:296-301
[67]Ombrellino M,Wang H,Ajemian MS,et al.Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock[J]. Lancet , 1999 ,354:1446-1447
[68]Hatada T,Wada H,Nobori T,et al.Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation[J].Thromb Haemost J,2005,94(5):975-979
[69]Sunden-Cullberg J,Norrby-Teglund A,Treutiger CJ.The role of high mobility group box-1 protein in severe sepsis[J].Current Opinion in Infectious Diseases,2006,19:231-236
[70]O’Connor KA,Hansen MK,Rachal Pugh C,et al.Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine:central nervous system effects[J].Cytokine,2003,24:254-265
[71]Kokkola R,Sundberg E,Ulfgren AK,et al.High mobility group box chromosomal protein 1:a novel proinflammatory mediator in synovitis[J]. Arthritis Rheum,2002,46:2598-2603
[72]Taniguchi N,Kawahara K,Yone K,et al.High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine[J].Arthritis Rheum,2003,48:971-981
[73]Popovic K , Ek M , Espinosa A , et al.Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skinlesions of patients with lupus erythematosus[J].Arthritis Rheum , 2005 ,52(11):3639-3645
[74]Ulfgren AK,Grundtman C,Alexandersson H,et al.Cortocosteroid- therapy downregulates the proinflammatory mediator HMGB1 in myositis patients[J].Arthritis Rheum,2004,Inpress
[75]王松柏,姚咏明,董宁等.JAK/STAT通路介导脓毒症大鼠肝组织高迁移率族蛋白B1 mRNA表达的研究[J].中国危重病急救医学,2003,15(3):147-149
[76]Yang H,Wang H,Czura CJ,et al.HMGB1 as a cytokine and therapeutic target[J].J Endotoxin Res,2002,8(6):469-472
[77]Yin K,Gribbin E,Wang H.Interferon-gamma inhibition attenuates lethality after cecal ligation and puncture in rats:implication of high mobility group box-1[J].Shock,2005,24(4):396-401
[78]Andersson U,Wang H,Palmblad K,et al.High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes[J].J Exp Med,2000,192(4):565-570
[79]Liu S,Stolz DB,Sappington PL,et al.HMGB1 is secreted by immuno- stimulated enterocytes and contributes to cytomix-induced hyperper- meability of Caco-2 monolayers[J].Am J Physiol Cell Physiol,2006, 290(4):990-999
[80]Sappington PL,Yang R,Yang H,et al.HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice[J].Gastroenterology,2002,123:790-802
[81]Sanford AN,Dietzmann K,Sullivan KE.Apoptotic cells, autoantibodies,and the role of HMGB1 in the subcellular localization of an autoantigen[J].J Autoimmun,2005,25(4):264-271
[82]Dumitriu IE,Baruah P,Manfredi AA,et al.HMGB1: guiding immunity from within[J].Trends Immunol,2005,26(7):381-387
[83]Remick D,Manohar P,Bolgos G,et al.Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture[J].Shock,1995,4:89-95
[84]Calandra T,Echtenacher B,Roy DL,et al.Protection from septic shock byneutralization of macrophage migration inhibitory factor[J].Nat Med , 2000 ,6:164-170
[85]Kokkola R,Li J,Sundberg E,et al.Successful treatment of collagen- induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity[J].Arthritis Rheum,2003,48:2052-2058
[86]Ulloa L,Ochani M,Yang H,et al.Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation[J].Proc Natl Acad Sci U S A,2002,99:12351-12356
[87]Yang R,Gallo DJ,Baust JJ,et al.Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock[J]. Am J Physiol Gastrointest Liver Physiol,2002,283:212-221
[88]Das UN.Pyruvate is an endogenous anti-inflammatory and anti-oxidant molecule[J].Med Sci Monit,2006,25,12(5):79-84
[89]Riedemann NC,Guo RF,Ward PA.Novel strategies for the treatment of sepsis [J].Nat Med,2003,9(5):517-524